Molecular biologist to get T'gana award for genome work

Image
Press Trust of India Hyderabad
Last Updated : Feb 05 2018 | 6:05 PM IST
Eminent molecular biologist Professor Michael N Hall of the Biozentrum University of Basel, Switzerland, has been chosen for the Genome Valley Excellence Award which will be presented to him during BioAsia 2018, an annual flagship event of the Telangana government.
The event begins on February 22, an official release stated, adding that Prof Hall will be presented the award during its opening ceremony.
The release informed that Prof Hall had been bestowed with the 2018 Genome Valley Excellence Award for his pioneering work in discovering the nutrient-activated TOR (Target of Rapamycin) proteins and their central role in the metabolic control of cell growth.
The award, instituted in 2004, was in recognition of the 'transformative advances toward biomedical research and facilitating improvement in human life' and was chosen by an international advisory board consisting of eminent personalities of the life sciences industry, it informed.
Announcing the 2018 Genome Valley Excellence Award, Telanganas Minister for Industries and Commerce, K T Rama Rao, said, "We are delighted to have an eminent expert like Professor Michael N Hall joining us at the BioAsia 2018. Professor Halls work in discovering the nutrient-activated TOR (Target of Rapamycin) proteins is a commendable achievement."
Rao further said that the event acted as a platform for the government to invite global investors, scientists and business leaders to showcase the extraordinary infrastructure available in the state.
According to the release, Prof Halls exhaustive research proved that the TOR system adjusts cell size in response to the availability of raw materials.
"TOR balances constructive and destructive activities to match accumulation of cell mass with nutrient supply and other growth signals, such as hormones," it said.
"Disruption of the TOR network contributes to numerous human illnesses, including diabetes and cancer, and has implications across various age-related disorders," the release informed.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 05 2018 | 6:05 PM IST

Next Story